<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kelly L</submitter><funding>NIA NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>1421-1435</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10917045</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(2)</volume><pubmed_abstract>This editorial summarizes advances from the Clearance of Interstitial Fluid and Cerebrospinal Fluid (CLIC) group, within the Vascular Professional Interest Area (PIA) of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). The overarching objectives of the CLIC group are to: (1) understand the age-related physiology changes that underlie impaired clearance of interstitial fluid (ISF) and cerebrospinal fluid (CSF) (CLIC); (2) understand the cellular and molecular mechanisms underlying intramural periarterial drainage (IPAD) in the brain; (3) establish novel diagnostic tests for Alzheimer's disease (AD), cerebral amyloid angiopathy (CAA), retinal amyloid vasculopathy, amyloid-related imaging abnormalities (ARIA) of spontaneous and iatroge</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy.</pubmed_title><pmcid>PMC10917045</pmcid><funding_grant_id>R01 AG055865</funding_grant_id><funding_grant_id>R01 AG062572</funding_grant_id><funding_grant_id>R01 NS104127</funding_grant_id><pubmed_authors>Elahi F</pubmed_authors><pubmed_authors>Agarwal N</pubmed_authors><pubmed_authors>Snyder H</pubmed_authors><pubmed_authors>Carare RO</pubmed_authors><pubmed_authors>Salib R</pubmed_authors><pubmed_authors>Mazer N</pubmed_authors><pubmed_authors>Brown C</pubmed_authors><pubmed_authors>Verma A</pubmed_authors><pubmed_authors>Koronyo-Hamaoui M</pubmed_authors><pubmed_authors>Ethell DW</pubmed_authors><pubmed_authors>Kelly L</pubmed_authors><pubmed_authors>Alzetani A</pubmed_authors><pubmed_authors>Ismail O</pubmed_authors><pubmed_authors>Piazza F</pubmed_authors><pubmed_authors>Counts SE</pubmed_authors><pubmed_authors>Proulx ST</pubmed_authors><pubmed_authors>Wunderlich H</pubmed_authors><pubmed_authors>de Leon M</pubmed_authors><pubmed_authors>Fossati S</pubmed_authors><pubmed_authors>Dodart JC</pubmed_authors><pubmed_authors>Haack M</pubmed_authors><pubmed_authors>Hawkes CA</pubmed_authors><pubmed_authors>Wolters FJ</pubmed_authors><pubmed_authors>Aldea R</pubmed_authors><pubmed_authors>Michalik D</pubmed_authors><pubmed_authors>Rich SA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy.</name><description>This editorial summarizes advances from the Clearance of Interstitial Fluid and Cerebrospinal Fluid (CLIC) group, within the Vascular Professional Interest Area (PIA) of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). The overarching objectives of the CLIC group are to: (1) understand the age-related physiology changes that underlie impaired clearance of interstitial fluid (ISF) and cerebrospinal fluid (CSF) (CLIC); (2) understand the cellular and molecular mechanisms underlying intramural periarterial drainage (IPAD) in the brain; (3) establish novel diagnostic tests for Alzheimer's disease (AD), cerebral amyloid angiopathy (CAA), retinal amyloid vasculopathy, amyloid-related imaging abnormalities (ARIA) of spontaneous and iatroge</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-07-15T21:31:50.905Z</modification><creation>2026-07-09T10:14:26.921Z</creation></dates><accession>S-EPMC10917045</accession><cross_references><pubmed>37897797</pubmed><doi>10.1002/alz.13512</doi></cross_references></HashMap>